ArticleMicroorganisms2025
More Is Not Always Better: Co-Occurrence Analysis of Anti-Phage Systems Reveals Prevalent Neutral Interactions in
Shuhong Han, Xiaofu Wan, Zixun Lin, Xiangke Duan, Yukun Zeng, Jiayin Shen, Hongzhou Lu
Abstract read
In one paragraphArticle in Microorganisms, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
7 authors.
Shuhong HanNational Clinical Research Center for Infectious Diseases, The Third People's Hospital of Shenzhen and The Second Affiliated Hospital of Southern University of Science and Technology, Shenzhen 518112, China.
Xiaofu WanNational Clinical Research Center for Infectious Diseases, The Third People's Hospital of Shenzhen and The Second Affiliated Hospital of Southern University of Science and Technology, Shenzhen 518112, China.
Zixun LinNational Clinical Research Center for Infectious Diseases, The Third People's Hospital of Shenzhen and The Second Affiliated Hospital of Southern University of Science and Technology, Shenzhen 518112, China.
Xiangke DuanNational Clinical Research Center for Infectious Diseases, The Third People's Hospital of Shenzhen and The Second Affiliated Hospital of Southern University of Science and Technology, Shenzhen 518112, China.
Yukun ZengNational Clinical Research Center for Infectious Diseases, The Third People's Hospital of Shenzhen and The Second Affiliated Hospital of Southern University of Science and Technology, Shenzhen 518112, China.
Jiayin ShenNational Clinical Research Center for Infectious Diseases, The Third People's Hospital of Shenzhen and The Second Affiliated Hospital of Southern University of Science and Technology, Shenzhen 518112, China.ORCID 0000-0002-2410-2808 Hongzhou LuNational Clinical Research Center for Infectious Diseases, The Third People's Hospital of Shenzhen and The Second Affiliated Hospital of Southern University of Science and Technology, Shenzhen 518112, China.
Funding
National Key R&D Program of China No. 2025YFC3408402Shenzhen Clinical Research Center for Emerging Infectious Diseases No. LCYSSQ20220823091203007Shenzhen Key Laboratory for Diagnosis and Treatment Technology of Infectious Diseases, Shenzhen High-level Hospital Construction Fund, and Shanghai Science and Technology Innovation Action Plan in 2022 No. 22N31900800the National Natural Science Foundation of China No. 82473753, No. 82070420
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
anti-phageco-occurrenceneutral effectsprokaryotic immunityPseudomonas aeruginosa
Identifiers
PMID41471986
PMCPMC12735699
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390